Why the study?
Do specific ECG and electrophysiological markers predict malignant tachyarrhythmias in patients with early stage arrhythmogenic cardiomyopathy and provocable Brugada ECG?
Do specific ECG and electrophysiological markers predict malignant tachyarrhythmias in patients with early stage arrhythmogenic cardiomyopathy and provocable Brugada ECG?
Specific ECG and electrophysiological markers are highlighted for risk stratification of malignant tachyarrhythmias in patients with early-stage arrhythmogenic cardiomyopathy and provocable Brugada ECG.
Answers are grounded in this paper and cite their sources.
These ECG markers may aid risk stratification in early ARVC with Brugada pattern; leaves open need for prospective validation.
Risk factors of malignant tachyarrythmias should be assessed in cases with early stage arrhythmogenic cardiomyopathy and provocable Brugada ECG. Spontaneous right precordial coved-type ST segment elevation, tall R wave in lead a VR, QRS fragmentation, 1 AV block, inducibility during electrophysiological examination, and localised right precordial QRS prolongation should be tested in 20 out of 128 patients.
No takes yet. Share an insight, caveat, or question.
Stefan Peters (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: